Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Laryngeal dystonia].

P Klap1, M Cohen, S van Prooyen Keyzes

  • 1Service d'Oto-Rhino-Laryngologie, Fondation Adolphe de Rothschild, Paris.

Revue Neurologique
|November 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

French translation and psychometric validation of the Client-Oriented Scale of Improvement (COSI) questionnaire.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

[Introductory Teaching on Transgender Identity in the Second Cycle of Medical Studies: Five Years of Experience].

Annales de chirurgie plastique et esthetique·2026
Same author

Differential impact of porcine reproductive and respiratory virus and swine Influenza A virus infections on respiratory Lymph Nodes B cells and macrophages.

Molecular immunology·2025
Same author

French-language questionnaires in ENT: Inventory and review.

European annals of otorhinolaryngology, head and neck diseases·2024
Same author

Abundant hydrocarbons in the disk around a very-low-mass star.

Science (New York, N.Y.)·2024
Same author

Burnout in ENT France: Update and risk factors; a STROBE analysis.

European annals of otorhinolaryngology, head and neck diseases·2024
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Laryngeal dystonia, including spasmodic dysphonia, causes voice and breathing issues. Botulinium toxin injections offer significant improvement for most patients, with surgery as a secondary option.

Area of Science:

  • Neurology
  • Otolaryngology

Context:

  • Laryngeal dystonia presents diverse phonatory and respiratory challenges.
  • Spasmodic dysphonia is a common manifestation, affecting voice quality and potentially causing breathing difficulties.

Purpose:

  • To outline diagnostic methods for laryngeal dystonia.
  • To review botulinium toxin treatment efficacy and techniques.
  • To discuss surgical options for refractory cases.

Summary:

  • Diagnostic tools include laryngeal video-fibroscopy and electromyography.
  • Botulinium toxin injections demonstrate high success rates (66.7-100%) for laryngeal dystonia.
  • Specific injection protocols for adductor and abductor spasmodic dysphonia are detailed.

Impact:

Related Experiment Videos

  • Botulinium toxin provides a highly effective treatment for laryngeal dystonia.
  • Surgical interventions can enhance outcomes when toxin therapy is insufficient.
  • Improved voice and respiratory function can be achieved through these therapeutic approaches.